| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/07/2002 | US20020016974 Transgenic, non-human animals containing a coxsackie/adenovirus receptor (CAR) |
| 02/07/2002 | US20020016762 Method and system for foreign exchange price procurement and automated hedging |
| 02/07/2002 | US20020016451 Solution phase biopolymer synthesis |
| 02/07/2002 | US20020016446 Recombinant vector and use thereof for exocellular preparation of single molecula antibodies from bacillus subtilis |
| 02/07/2002 | US20020016443 Antiproliferative factor |
| 02/07/2002 | US20020016305 Yeast genes that affect viral replication |
| 02/07/2002 | US20020016303 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease. |
| 02/07/2002 | US20020016295 Keratinocyte growth factor-2 formulations |
| 02/07/2002 | US20020016291 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| 02/07/2002 | US20020016286 Simultaneous administration of human growth hormone in combination with DHEA, or their precursors, releasers, analogs, or metabolites; regenerating the human thymus to allow intrathymic transplantation |
| 02/07/2002 | US20020015998 Novel G protein-coupled receptors |
| 02/07/2002 | US20020015989 Isolated nucleic acids from micromonospora rosaria plasmid pMR2 and vectors made therefrom |
| 02/07/2002 | US20020015983 Escherichia coli csrB gene, RNA encoded thereby, and methods of use thereof |
| 02/07/2002 | US20020015981 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 02/07/2002 | US20020015980 Neurotransmitter transporter |
| 02/07/2002 | US20020015972 Immunoglobulin; for use as diagnostic tool in immunoassays |
| 02/07/2002 | US20020015967 Functional expression of adenosine receptors in yeast |
| 02/07/2002 | US20020015950 Atherosclerosis-associated genes |
| 02/07/2002 | US20020015738 Peptides; animal extracts |
| 02/07/2002 | US20020015711 Remove pertussis toxin and filamentous haemagglutinin from Bordetella pertussis, precipitating pertactin by ammonium sulphate, passing through hydroxyapatite and Q-Sepharose and ultrafilitrating |
| 02/07/2002 | US20020015710 Mimicing the conformational neutralizing epitopes on papilloma virions |
| 02/07/2002 | US20020015703 Monoclonal antibodies or soluble immunoglobulin fusion proteins to block the development of chronic Graft-Versus-Host Disease |
| 02/07/2002 | US20020015696 Modulation of expression of nucleotide sequences encoding transcription factors; antidiabetic agents |
| 02/07/2002 | DE10053879A1 Genexpression, Genomalteration und Reporterexpression in Myofibroblasten und myofibroblast-ähnlichen Zellen Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 02/07/2002 | DE10048383A1 Protonen-translozierendes Retinalprotein Proton-translocating retinal protein |
| 02/07/2002 | DE10037111A1 Herstellung eines rekombinanten Proteins in einer prokaryontischen Wirtszelle Producing a recombinant protein in a prokaryotic host cell |
| 02/07/2002 | DE10036461A1 Ligandenbindedomäne des Ultraspiracle (USP)-Proteins Ligand binding domain of the Ultraspiracle (USP) protein |
| 02/07/2002 | DE10035854A1 Schlangentoxin und dessen Verwendung als Arzneimittel Snake toxin and its use as a medicament |
| 02/07/2002 | DE10035156A1 New protein complex containing complex protein from botulinum toxin, useful for oral delivery of therapeutic polypeptide or low molecular weight pharmaceutical |
| 02/07/2002 | DE10032529A1 Diagnose von bedeutenden genetischen Parametern innerhalb des Major Histocompatibility Complex (MHC) Diagnosis of important genetic parameters within the major histocompatibility complex (MHC) |
| 02/07/2002 | CA2418120A1 High affinity integrin polypeptides and uses thereof |
| 02/07/2002 | CA2417900A1 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | CA2417885A1 Cell internalized peptide-drug conjugates |
| 02/07/2002 | CA2417873A1 Secretase/sheddase with asp-ase activity on the beta-site app-cleaving enzyme (bace, asp2, memepsin 2) |
| 02/07/2002 | CA2417719A1 Improved virus like particles based on small envelope protein from hepatitis b (hbsag-s) |
| 02/07/2002 | CA2417703A1 Methods and compositions for diagnosing and treating chromosome-18p related disorders |
| 02/07/2002 | CA2417671A1 Trp8, trp9 and trp10, novel markers for cancer |
| 02/07/2002 | CA2417642A1 Novel human ion channel proteins and polynucleotides encoding the same |
| 02/07/2002 | CA2417612A1 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | CA2417568A1 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 02/07/2002 | CA2417564A1 Novel regulatory genes involved in condensed tannin synthesis in plants |
| 02/07/2002 | CA2417454A1 Peptide-mediated delivery of molecules into cells |
| 02/07/2002 | CA2417364A1 Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses |
| 02/07/2002 | CA2417349A1 Novel proteins and nucleic acids encoding same |
| 02/07/2002 | CA2417340A1 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene |
| 02/07/2002 | CA2417278A1 Identification of a novel glutamine transporter |
| 02/07/2002 | CA2417271A1 Novel protein inhibitor of apoptosis proteins |
| 02/07/2002 | CA2417195A1 G-protein coupled receptors |
| 02/07/2002 | CA2417100A1 Modified peptides with increased potency |
| 02/07/2002 | CA2417087A1 Mammalian dna binding membrane-associated protein-encoding gene and uses |
| 02/07/2002 | CA2416981A1 Synchronised arabidopsis cell suspensions and uses thereof |
| 02/07/2002 | CA2416893A1 Modified cea and uses thereof |
| 02/07/2002 | CA2416820A1 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 02/07/2002 | CA2416732A1 Endothelial cell expression patterns |
| 02/07/2002 | CA2416710A1 Methods of controlling gene expression and gene silencing |
| 02/07/2002 | CA2416260A1 Promyostatin peptides and methods of using same |
| 02/07/2002 | CA2416156A1 Accessory cholera enterotoxin and analogs thereof as activators of calcium dependent chloride channel |
| 02/07/2002 | CA2416137A1 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 02/07/2002 | CA2415647A1 Neospora caninum isolate |
| 02/07/2002 | CA2415436A1 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 02/07/2002 | CA2415433A1 A human disintegrin protein |
| 02/07/2002 | CA2414602A1 Silicatein-mediated synthesis of amorphous silicates and siloxanes and their uses |
| 02/07/2002 | CA2385910A1 Somatostatin analogs for the treatment of cancer |
| 02/06/2002 | EP1178116A1 Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof |
| 02/06/2002 | EP1178115A2 Phosphodiesterase |
| 02/06/2002 | EP1178111A1 Vaccination against host cell-associated herpesviruses |
| 02/06/2002 | EP1178110A1 EDG8 receptor for sphingosine 1-phosphate , its preparation and use |
| 02/06/2002 | EP1178053A2 Polypeptides and polynucleotides coding therefor from a family of G-protein coupled receptors and their use for the diagnosis and treatment of skin diseases |
| 02/06/2002 | EP1178052A2 Genes identified as required for proliferation in Escherichia coli |
| 02/06/2002 | EP1177440A1 Secreted proteins and polynucleotides encoding them |
| 02/06/2002 | EP1177439A1 Screening for immunostimulatory dna functional modifyers |
| 02/06/2002 | EP1177435A1 Non-mammalian transgenic animal having an adult onset neurodegenerative phenotype |
| 02/06/2002 | EP1177313A2 Method for localising proteases which split substrates that are specifically connected by a membrane |
| 02/06/2002 | EP1177312A2 Human gil-19/ae289 proteins and polynucleotides encoding same |
| 02/06/2002 | EP1177311A1 In vitro macromolecule biosynthesis methods using exogenous amino acids and a novel atp regeneration system |
| 02/06/2002 | EP1177307A2 Disease resistance factors |
| 02/06/2002 | EP1177306A2 Plant defensins |
| 02/06/2002 | EP1177305A1 Method for producing a recombinant protein |
| 02/06/2002 | EP1177304A2 Modified vitamin k-dependent polypeptides |
| 02/06/2002 | EP1177301A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 02/06/2002 | EP1177300A1 Seed specific promoters |
| 02/06/2002 | EP1177299A2 Auxin transport proteins |
| 02/06/2002 | EP1177298A1 Autotaxin variants and uses to treat diseases of metabolism |
| 02/06/2002 | EP1177297A2 Novel nucleic acids and proteins with growth hormone activity |
| 02/06/2002 | EP1177296A2 Extracellular matrix and adhesion-associated proteins |
| 02/06/2002 | EP1177295A1 Ox2 receptor homologs |
| 02/06/2002 | EP1177294A1 Novel cellular regulation factor tto 20 |
| 02/06/2002 | EP1177293A1 Growth factor homolog zvegf4 |
| 02/06/2002 | EP1177292A2 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 02/06/2002 | EP1177291A2 Laminin 8 and methods for its use |
| 02/06/2002 | EP1177290A2 Recombinant laminin 5 |
| 02/06/2002 | EP1177289A1 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 02/06/2002 | EP1177288A1 Tumour-associated antigen |
| 02/06/2002 | EP1177287A2 Secreted human proteins |
| 02/06/2002 | EP1177286A1 Mdm interacting protein and methods of use thereof |
| 02/06/2002 | EP1177285A1 Chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
| 02/06/2002 | EP1177282A1 Combinatorial metabolic libraries |
| 02/06/2002 | EP1177277A2 Compositions and methods for the modification of gene transcription |
| 02/06/2002 | EP1177215A1 Constitutive chimeric receptors, and methods of use thereof |
| 02/06/2002 | EP1177214A1 49 human secreted proteins |